<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                                      REPORT <br /> Exome Sequencing Functional Validation Zebrafish Identify GTDC2 Mutations Cause Walker-Warburg Syndrome <br /> M. Chiara Manzini,1,2 Dimira E. Tambunan,1,2 R. Sean Hill,1,2 Tim W. Yu,1,2 Thomas M. Maynard,3 <br /> Erin L. Heinzen,4 Kevin V. Shianna,4 Christine R. Stevens,5 Jennifer N. Partlow,1,2 Brenda J. Barry,1,2 <br /> Jacqueline Rodriguez,1,2 Vandana  Gupta,1,6 Abdel-Karim Al-Qudah,7 Wafaa M. Eyaid,8 <br /> Jan M. Friedman,9,10 Mustafa  Salih,11 Robin Clark,12 Isabella Moroni,13 Marina Mora,14 <br /> Alan H. Beggs,1,6 Stacey B. Gabriel,5 Christopher  Walsh1,2,5,* <br />  exome sequencing (WES), analyzes coding sequence annotated genes human genome, ideal <br /> approach studying fully penetrant autosomal-recessive diseases, powerful identifying disease-causing muta- <br /> tions enrollment affected individuals limited reduced survival. study, combined WES homozygosity <br /> analysis consanguineous pedigrees, informative single affected individual available, identify genetic <br /> mutations responsible Walker-Warburg syndrome (WWS), genetically heterogeneous autosomal-recessive disorder severely <br /> affects development brain, eyes, muscle. Mutations seven genes known cause WWS explain 50%&#226;&#8364;&#8220;60% cases, multiple additional genes expected mutated unexplained cases suggestive linkage diverse loci. Using <br /> WES consanguineous WWS-affected families, multiple deleterious mutations GTDC2  known AGO61). GTDC2&#226;&#8364;&#8482;s <br /> predicted role uncharacterized glycosyltransferase consistent function genes known mutated WWS involved glycosylation transmembrane receptor dystroglycan.  explore role GTDC2 <br /> loss function development, used morpholino-mediated knockdown zebrafish ortholog, gtdc2. gtdc2 <br /> knockdown zebrafish replicates WWS features (hydrocephalus, ocular defects, muscular dystrophy), strongly suggesting GTDC2 mutations cause WWS. <br />  <br /> Walker-Warburg syndrome (WWS, known                                    19; Table S1, available online). subjects enrolled <br /> MDDGA1&#226;&#8364;&#8220;7 [MIM 236670, 613150, 253280, 253800,                                  informed consent obtained, research <br /> 613153, 613154, 614643]) severe neuromuscular                         conducted according protocols approved disorder characterized congenital muscular dystrophy,                       institutional review board Boston Children&#226;&#8364;&#8482;s Hospital. <br /> ocular malformations, smooth appearance cortical                        affected individuals diagnosed classic WWS <br /> surface accompanied neuronal migration defects                              basis following criteria: (1) brain malfor- <br /> (cobblestone lissencephaly), ventricular enlargement                       mation characterized cobblestone lissencephaly (hydrocephalus).1,2 Mutations seven genes (POMT1                            neuroimaging, severe hydrocephalus, cerebellar <br /> [MIM 607423], POMT2 [MIM 607439], POMGNT1 [MIM                                 hypoplasia; (2) presence ocular malformations <br /> 606822], FKTN [MIM 607440], FKRP [MIM 606596],                                 (microphthalmia macrophthalmia, retinal dysplasia, <br /> LARGE [MIM 603590], ISPD [MIM 614631]) known                           optic nerve hypoplasia, anterior chamber defects); cause WWS2&#226;&#8364;&#8220;5 identified 50%&#226;&#8364;&#8220;60%                          (3) clinical diagnosis, usually based severe hypo- <br /> cases.4,6&#226;&#8364;&#8220;8 Identification additional genes mutated                      tonia, congenital muscular dystrophy.1,9 Serum <span id='am-2' about='obo:IMR_0200144' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="KEGG:C00300" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="Creatine" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:id" content="IMR:0200144" datatype="xsd:string"></span>creatine</span> <br /> WWS hindered small size available                       kinase histopathological confirmation muscular <br /> pedigrees, DNA available                        dystrophy available cases affected individuals. increase power                       clinical severity reduced lifespan associated stand genetic architecture WWS identify                          condition. <br /> mutations additional genes, collected cohort                          determined pattern homozygosity affected individuals consanguineous marriages (n &#194;&#188;                        consanguineous pedigrees hybridizing genomic <br />  <br /> 1 <br />   Division Genetics, Manton Center Orphan Disease Research, Boston Children&#226;&#8364;&#8482;s Hospital, Boston, MA 02115, USA; 2Howard Hughes Medical <br /> Institute, Boston Children&#226;&#8364;&#8482;s Hospital, Boston, MA 02115, USA; 3Department Pharmacology Physiology, George Washington University School Medicine, Washington, DC 20037, USA; 4Department Medicine, Center Human Genome Variation, Duke University School Medicine, Durham, <br /> NC 27708, USA; 5Program Medical Population Genetics, Broad Institute MIT Harvard, Cambridge, MA 02142, USA; 6Genomics Program, <br /> Boston Children&#226;&#8364;&#8482;s Hospital, Boston, MA 02115, USA; 7Department Pediatrics, University Jordan, 11941 Amman, Jordan; 8Department Pediatrics, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia; 9Department Medical Genetics, University British Columbia, Vancouver, BC <br /> V5Z 4H4, Canada; 10Child Family Research Institute, Vancouver, BC V5Z 4H4, Canada; 11Division Pediatric Neurology, Department Pediatrics, <br /> King Saud University College Medicine, Riyadh 11461, Saudi Arabia; 12Division Genetics, Department Pediatrics, Loma Linda University Medical <br /> Center, Loma Linda, CA 92354, USA; 13Division Pediatric Neurology, Fondazione Istituto di Ricerca e Cura Carattere Scientifico Istituto Neurologico C. <br /> Besta, 20126 Milan, Italy; 14Division Neuromuscular Diseases Neuroimmunology, Fondazione Istituto di Ricerca e Cura Carattere Scientifico <br /> Istituto Neurologico C. Besta, 20126 Milan, Italy <br /> *Correspondence: christopher.walsh@childrens.harvard.edu <br /> http://dx.doi.org/10.1016/j.ajhg.2012.07.009. &#195;&#8220;2012 American Society Human Genetics. rights reserved. <br />  <br />  <br />  <br />  <br />                                                                 American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 541 <br />  Table 1.   Clinical Features Individuals FKTN, POMT2, GTDC2 Mutations <br />                                                 Cobblestone            Enlarged       Cerebellar <br /> Person        Age Exam         Gene          Lissencephaly          Ventricles     Hypoplasia    Ocular Defects        Muscular Defects <br />  <br /> 82-1          2 months            FKTN          &#195;&#190;                      &#195;&#190;              &#195;&#190;             retinal dysplasia,    CK &#194;&#188; 44,566 U/la <br />                                                                                                     glaucoma <br />  <br /> 144-1         6 months            POMT2         &#195;&#190;                      &#195;&#190;              &#195;&#190;             glaucoma              hypotonia <br />  <br /> 86-1          23 weeks            GTDC2         &#195;&#190;                      &#195;&#190;              &#195;&#190;                                     <br />  <br /> 86-2          20 weeks                          &#195;&#190;                      &#195;&#190;              &#195;&#190;             N                   N  <br /> 90-1          2 months            GTDC2         &#195;&#190;                      &#195;&#190;              &#195;&#190;             retinal dysplasia     hypotonia <br />  <br /> 100-1         1 month             GTDC2         &#195;&#190;                      &#195;&#190;              &#195;&#190;             microphthalmia    hypotonia <br />                                                                                                     macrophthalmia <br />  following abbreviations used: CK, creatine kinase; N  available.  Normal CK range: 40&#226;&#8364;&#8220;180 U/l. <br />  <br />  <br />  <br /> DNA probands available family members                           (1) likely pathogenic (missense nonsense genome SNP arrays&#226;&#8364;&#8221;Affymetrix 250K StyI                            variants, frameshift indels, splicing errors lumina 610-Quad W.M. Keck Foundation Biotech-                             10 bp splice site), (2) novel rare (minor allele <br /> nology Resource Laboratory Yale University. Genotyp-                          frequency &lt; 0.5%) control cohort ing data analyzed house-developed software                          7,000 control individuals (1,000 Genomes November identification regions homozygosity (ROHs)                         2011 release, 5,379 exomes National Heart, genome, genes known mutated                             Lung, Blood Institute [NHLBI] Grand Opportunity WWS sequenced contained                               Exome Sequencing Project, 69 genomes Complete ROH present affected individual.                          Genomics, 821 house Walsh lab exomes), (3) previously reported,6 homozygous mutations                            ROH propositus, (4) inherited families (8 19; 42%) (Table S1). Homozygosity                        autosomal-recessive pattern family analysis remaining 11 families identified average                      Sanger sequencing parents unaffected siblings. <br /> percentage homozygosity 9.3% (1.3% 5 standard                              Filtered variants Middle Eastern individuals, error mean), larger expected 6%                         widely represented exome databases, cousin union10 suggests increased                           genotyped 384 ethnically matched individ- <br /> ground consanguinity captured                           uals mass-spectrometry-based Sequenom SNP geno- <br /> available nuclear pedigrees (Table S1). Multiple regions                         typing Intellectual Developmental Disabilities shared families, expected                        Research Center (IDDRC) Molecular Genetics Core chance type cohort, fact region                       Boston Children&#226;&#8364;&#8482;s Hospital confirming vari- <br /> overlapped families indicates                            ants rare population-specific polymorphisms. <br /> multiple additional genes remain identified.                               approach narrowed number variants    percentage homozygosity cohort high                         average number candidates family (Table S2). sufficient reduce number candidate genes                          Homozygous mutations genes known involved thousand sample.                            WWS identified affected individuals performed exome sequencing (WES) analysis                               families (Figure S1); homozygous 1 bp inser- <br /> study candidate genes 11 Seven remain-                        tion leading frameshift change (c.642dup [p.Asp215*]) <br /> ing probands suitable WES, exome                              (NM_006731.2) FKTN family 82, cousin <br /> DNA libraries prepared genomic DNA                                  union Hispanic ethnicity United States (Table <br /> hybridization Agilent SureSelect Exon 37Mb                          1 Figures S1A S1B), homozygous missense <br /> kit run Illumina HiSeq2000 machine                                change (c.1433A&gt;G [p.His478Arg]) (NM_013382.4) Duke Center Human Genome Variation                             POMT2 family 144, second-cousin union Durham, NC Broad Institute MIT                               Sudan (Table 1 Figures S1C S1D). missense <br /> Harvard Cambridge, MA. Sequencing reads                                  change obtained highest pathogenicity score aligned Human Reference Genome (UCSC hg19)                                independent pathogenicity prediction algorithms, Poly- Burrows-Wheeler Aligner software.12 Variant calling                         phen214 SIFT15 (Polyphen2 &#194;&#188; 1 [probably damaging]; performed SAMtools software,12                               SIFT &#194;&#188; 0 [damaging]). Despite present large <br /> SequenceVariantAnalyzer ANNOVAR13 used                                ROH affected individuals, genes annotating variants. Sequencing yielded average                            previously sequenced family, 49,538 variants individual  Table S2 WES statis-                     smaller homozygous region identical haplotype <br /> tics). Variants filtered custom MySQL                             present gene parents <br /> queries identification recessive mutations,                     likely common haplotype  <br />  <br /> 542 American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 <br />  Figure 1. Independent Alleles GTDC2 Cause WWS <br />   Pedigree structure family 90 (DNA available individuals marked asterisks) T2-weighted axial magnetic resonance <br /> images (MRIs) propositus. MRI left shows microphthalmia macrophthalmia (asterisks) cerebellar hypoplasia <br /> (red arrow), MRI right shows severe ventricular enlargement cortical-migration defects characteristic cobblestone <br /> lissencephaly (inset). <br /> (B) Pedigree structure family 100 coronal MRIs propositus. images degree malformation similar seen family 90. <br /> (C&#226;&#8364;&#8220;D) Sanger sequencing confirming mutations identified WES families 90 100. <br /> (E) Conservation arginine 158 surrounding region vertebrates. <br /> (F) Sanger sequencing additional GTDC2 nonsense mutation identified family 86. <br /> (G) Schematics showing overlapping regions homozygosity families affected GTDC2 mutations GTDC2 <br /> protein structure including predicted functional domains. Locations mutations listed protein. <br />  <br />  <br /> population. findings illustrate power WES            90 100, respectively (Figure 1G). phenotypes identify disease-causing mutations unbiased                    families undistinguishable manner known disease genes tested                 classic WWS cases included <br /> independently.                                                       cobblestone lissencephaly, severe hydrocephalus, severe <br />    analyzed variants remaining WWS-               hypoplasia cerebellar vermis, muscle hypotonia <br /> affected families identified independent homozy-             (Table 1 Figures 1A 1B). muscle biopsy gous changes glycosyltransferase-like domain-containing           performed affected individuals died 2 (GTDC2), single-exon gene short arm (3p22.1)           days weeks birth. <br /> chromosome 3 (Figure 1). variant nonsense               WWS severe spectrum dystroglycan- <br /> change (c.1333C&gt;T [p.Arg445*]) (NM_032806.4) male               glycosylation disorders affecting muscle, eyes, Jordanian cousin union (family 90, Figure 1C)           brain. variable severity commonly defined led possible early truncation GTDC2 (Figure 1G);         muscular-dystrophy dystroglycanopathies (MDDGB1&#226;&#8364;&#8220;6 second variant missense change predicted                [MIM 613155, 613156, 613151, 613152, 606612, deleterious affected conserved <span id='am-21' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-22' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-27' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span>              608840] MDDGC1&#226;&#8364;&#8220;5 MDDGC7 [MIM 609308, <br /> (c.473G [p.Arg158His]; Polyphen2 &#194;&#188; 1 [probably                     613158, 613157, 611588, 607155, 613818]).7,9,16 damaging] SIFT &#194;&#188; 0 [damaging]) female Saudi          sequenced GTDC2 validation cohort nonconsangui- <br /> family (family 100, Figures 1D 1E). change              neous cases (n &#194;&#188; 52) spanning dystroglycanopathy <br /> contained large ROH: 25.8 Mb 28.1 Mb families            phenotypic spectrum identify additional alleles.  <br />  <br />                                                        American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 543 <br />                                                                                      Figure 2. Expression GTDC2                                                                                     Orthologs Mice Zebrafish <br />                                                                                       qPCR analysis GTDC2 mRNA expres- <br />                                                                                     sion fetal adult human tissues. High <br />                                                                                     expression stages                                                                                     brain, muscle, kidneys, heart.                                                                                     adult brain, cerebellum cortex <br />                                                                                     highest expression. Error bars <br />                                                                                     represent standard error                                                                                     sample repeats normalized beta-actin. <br />                                                                                     (B) Murine Gtdc2 expressed brain <br />                                                                                     development. E14.5 (left panels), <br />                                                                                     expression observed                                                                                     cortical plate (cp) developing <br />                                                                                     brain, eye, <br />                                                                                     including lens cornea. staining <br />                                                                                     evident sense control. scale <br />                                                                                     bars left panels represent 200 mm. <br />                                                                                     Cortical expression (right panels) peaks <br />                                                                                     E14.5 E16.5 reduced <br />                                                                                     birth (P0). scale bar right <br />                                                                                     panel represents 100 mm. <br />                                                                                     (C) situ hybridization zebrafish gtdc2 <br />                                                                                     1 dpf shows expression                                                                                     body; highest staining brain <br />                                                                                     eye boundaries                                                                                     somites (arrowheads inset). scale <br />                                                                                     bar represents 150 mm. <br />  <br />  <br />  <br />  <br />                                                                                      LARGE  gene involved                                                                                      dystroglycanopathies), pre- <br />                                                                                      dicted encode xylosyltrans- <br />                                                                                      ferase.20 studied expression                                                                                      GTDC2 mRNA multiple human <br />                                                                                      tissues using quantitative PCR <br />                                                                                      (qPCR) fetal develop- <br /> identified additional nonsense allele family 86,      ment adult. cDNA samples postmortem <br /> Indian family pregnancies terminated         fetal adult human tissues obtained commercially result diagnosis ventricular enlargement   (BioChain Institute Clontech). qPCR performed <br /> gestation. fetuses female diagnosed         SYBR Green reagents (Applied Biosystems) WWS autopsy (Table 1). DNA available             ABI 7500 qPCR platform previously described21 affected individuals, sequencing       primers hGTDC2_F 50 -GCGGAGTCCAGGCTTCAGGCT <br /> revealed homozygous GTDC2 mutation (c.590G                 TTC-30 hGTDC2_R 50 -CCGCCGAGAGGTGCATCCT <br /> generating stop codon amino acid 197 (p.Trp197*;          AATG-30 normalizing expression values beta-actin <br /> Figure 1F). family displayed small total       (ACTB). <br /> homozygosity (1%) regions larger               fetal adult stages, GTDC2 expression 5 cM, GTDC2 contained largest (7.5 Mb       especially high brain, muscle, heart, kidneys <br /> 5.9 cM) regions chromosome 3 (Figure 1G)&#226;&#8364;&#8221;          (Figure 2A), variably affected dystroglycan- <br /> suggesting parents distantly related.        opathy cases.6,22 Brain expression highest cortex <br />    GTDC2 ideal candidate gene WWS            cerebellum (Figure 2A), high expression predicted multiple protein-domain prediction algo-    noted pancreas (Figure S2A). analyze possible <br /> rithms contain uncharacterized glycosyltransferase       changes cellular distribution, analyzed expression domain (Figure 1G). genes mutations          murine ortholog GTDC2, Gtdc2, situ hybridiza- identified <span id='am-1' about='oboInOwl:date' typeof='owl:Thing'>date</span> involved glycosylation       tion (performed Situ Hybridization Core Facility transmembrane protein dystroglycan,          University North Carolina School Medicine glycosylated order interact extracellular matrix    Chapel Hill, NC) probe amplified embryonic <br /> components laminins, binding essential     day (E)12.5 mouse brain cDNA library  kind gift brain, eye, muscle integrity.2,17&#226;&#8364;&#8220;19 GTDC2    Byoung Bae Boston Children&#226;&#8364;&#8482;s Hospital) (primers <br /> alternatively called AGO61) predicted homology        mGtdc2-forward 50 -TTCCCTTACGCTGTCAATCC-30 <br /> belong glycosyltransferase family 61,  similar       mGtdc2-reverse 50 -TACGTGTTCTCCCCTTGCTC-30 ). <br />  <br />  <br /> 544 American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 <br />  Gtdc2 highly expressed brain          gtdc2 knockdown severely affected survival: 43.4% eye development; peaks cerebral cortex        embryos died 3 days injection. week gestation neuronal progenitors      clutchmates uninjected injected ventricular zone migrating differentiating         control MO displayed survival rates 98.4% neurons declines birth, supporting role       89.0%, respectively (Figure S3A). Surviving morphants gene neuronal development (Figure 2B),         3 dpf shorter controls bent did observe differential expression neuronal         tail, impaired motility, smaller eyes retina <br /> progenitors neuronal subtypes.                              failed fuse ventrally, domed appearance     test GTDC2 loss function affect brain      head (Figures 3D 3G Figure S3B). muscle development, used zebrafish,           pigmentation blocked 1 dpf recently established animal model           addition 0.003% 1-phenyl 2-thiourea water, <br /> dystroglycanopathies.23&#226;&#8364;&#8220;26 mRNA zebrafish          external analysis head revealed extreme ventricular <br /> ortholog (gtdc2) GTDC2 expressed zebrafish       enlargement (hydrocephalus), accompanied embryo larva development;             hemorrhaging (Figure 3G), affected larvae (Fig- <br /> especially high expression developing brain, eyes,      ure 3E). Ventral compression reduction brain somites (Figure 2C Figure S2B), consistent        volume evident histological analysis coronal <br /> expression zebrafish orthologs genes           cryosections stained DAPI (Figure 3E). Disorganiza- <br /> mutated WWS.27,28 Zebrafish situ hybridization       tion retinal epithelium observed performed according standard protocols29 probe       morphants; variable severity ultrathin <br /> amplified mixed 20-somite 5 day postfertilization    plastic-embedded sections stained 1% toluidine blue <br /> (dpf) zebrafish cDNA library  kind gift Peter Wang     1% sodium borate (Figure S3C) Conventional <br /> Boston Children&#226;&#8364;&#8482;s Hospital) (primers zfgtdc2-forward      Electron Microscopy Facility Harvard Medical School. <br /> 50 -ATGCACATTTTCCACGATGA-30 zfgtdc2-reverse                Finally, muscle development severely disrupted 50 -AACGACTGCTCCTCCAAAGA-30 ). knock                   loss dystrophin glycosylated dystroglycan <br /> gtdc2, tested different antisense morpholino oligo-     myosepta, junction muscle fibers nucleotides (MOs) targeted interfere gtdc2 trans-      extracellular matrix enriched (Figure 3F). <br /> lation blocking start codon (gtdc2Start:         Disorganization muscle fibers observed <br /> 50 -CCGGCAGGTTCATCCTACACCCGAT-30 ) splice               histology (Figure S3D). phenotypes (hydro- <br /> donor site intron present gene          cephalus retinal muscle defects) hallmarks fish (gtdc2Splice: 50 -TTATCATAACCCTGTGCACCT               WWS consistent eye, muscle, GTGA-30 ). MOs injected fertilized        brain phenotypes observed morphants genes  zebrafish oocytes, provided similar results (gtdc2Start   POMT1, POMT2, FKTN, FKRP, ISPD) previously 3&#226;&#8364;&#8220;5 ng gtdc2Splice 7&#226;&#8364;&#8220;10 ng).  data    mutated WWS.24&#226;&#8364;&#8220;26,28 phenotypes gtdc2Start shown. standard control MO         ameliorated GTDC2 mRNA injections provided Gene Tools used control       embryos analyzed 2 3 dpf (Figure 3G concentration used experimental MO injections.         Figure S3E). <br /> Injected embryos/larvae uninjected clutchmate                 summary, combined exome se- <br /> controls analyzed 0, 1, 2, 3 dpf survival      quencing, homozygosity mapping, functional anal- morphology tail, head, eyes. Develop-           ysis zebrafish identify validate GTDC2 mutations <br /> mental defects gtdc2 morphants evident 1          cause WWS. addition, reduced dpf quarter embryos severely affected          number candidate variants families short body, poorly developed tail,       manageable number variants family. discernible eyes head structures. Half        approach likely yield additional mutated genes <br /> morphants mildly affected scored            future help unravel pathways involved combination phenotypes: tail, U-shaped somites,       WWS determine role different glycosyltrans- <br /> reduced mobility inside chorion, small head,         ferases brain muscle development. <br /> underdeveloped eyes, ventral fusion retina delayed (Figure 3A). asked coinjection vitro-synthesized human GTDC2 mRNA             Supplemental Data <br /> gtdc2 MO improve phenotypes              Supplemental Data include figures tables case (Figure 3B).  rescue     article online http://www.cell.com/AJHG. <br /> effect observed tested mRNA mutated include p.Arg158His allele (Figure 3C). Arg158 <br /> residue highly conserved GTDC2, located     Acknowledgments beginning glycosyltransferase domain;         thank families enrolled studies fore, possible change severely impair    physicians contributed individuals validation <br /> protein function.                                              cohort. EuroBioBank Telethon Network Genetic Biobanks <br />  <br />  <br />  <br />                                                   American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 545 <br />                                                                                             Figure 3. Loss gtdc2 Zebrafish <br />                                                                                            Embryo Recapitulates Phenotypes Ob- <br />                                                                                            served WWS <br />                                                                                              Mild (center) severe (right) pheno- <br />                                                                                            types observed 1 dpf zebrafish <br />                                                                                            embryo injection MO designed <br />                                                                                            start site gtdc2. <br />                                                                                            (B) Phenotypes observed 1 dpf                                                                                            rescued coinjection gtdc2 MO <br />                                                                                            150 pg GTDC2 mRNA,                                                                                            effect observed injection                                                                                            mRNA (hGTDC2). <br />                                                                                            (C) Coinjection 150 pg GTDC2 <br />                                                                                            mRNA containing p.Arg158His alter- <br />                                                                                            ation able rescue morphant <br />                                                                                            phenotype. Representative experiments <br />                                                                                            shown. <br />                                                                                            (D) Surviving morphants 3 dpf                                                                                            developmental defects: reduced <br />                                                                                            length, bent tail, failure ventral retinal <br />                                                                                            fusion, dysmorphic head shape. <br />                                                                                            (E) 3 dpf morphants display hydro- <br />                                                                                            cephalus (lower left panel: mount <br />                                                                                            nonpigmented larva [asterisk])                                                                                            ventral compression remaining <br />                                                                                            brain tissue (lower right panel: DAPI stain- <br />                                                                                            ing histological section location <br />                                                                                            matching wild-type [WT] section <br />                                                                                            . scale bar represents 200 mm. <br />                                                                                            (F) Immunohistochemistry sections <br />                                                                                            WT morphant muscle shows <br />                                                                                            expression dystrophin <br />                                                                                            (green, left) glycosylated dystroglycan <br />                                                                                            (green, right) reduced myosepta <br />                                                                                            (marked arrowheads). Nuclei                                                                                            labeled DAPI (blue). scale bar repre- <br />                                                                                            sents 50 mm. <br />                                                                                            (G) Rescue GTDC2 mRNA                                                                                             right) ameliorates severe head <br />                                                                                            phenotypes observed morphant <br />                                                                                            (center). phenotypes failure                                                                                            retinal fusion (arrowhead), hydrocephalus <br />                                                                                            (asterisk), hemorrhage (arrow).                                                                                            scale bar represents 200 mm. <br />  <br />  <br />  <br />  <br /> (GTB07001F) acknowledged providing biological          supported Intellectual Developmental Disabilities <br /> samples. grateful J. Barkovich help   Research Centers (P30HD19655). Sequencing Broad Insti- <br /> review magnetic resonance imaging scans. M.C.M.          tute supported grant NIH American <br /> supported Junior Faculty Career Development Award         Recovery <span id='am-14' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-15' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span>amp</span>; Reinvestment Act (National Institute Mental Manton Center Orphan Disease Research K99/R00         Health RC2MH089952). C W. Investigator Howard <br /> Transition Independence award National Institutes       Hughes Medical Institute. Health (NIH) (National Institute Child Health &amp; Human <br /> Development, K99HD067379). T.W.Y. supported NIH            Received: April 10, 2012 <br /> T32 grant (T32NS007484-08), Clinical Investigator Training      Revised: June 16, 2012 <br /> Program Harvard-MIT Health Science Technology,           Accepted: July 11, 2012 Nancy Lurie Marks Junior Faculty MeRIT Fellowship. Research     Published online: September 6, 2012 supported grants NIH (National Institute Neurological Disorders Stroke R01NS035129 C W. National Institute Arthritis Musculoskeletal         Web Resources <br /> Skin Diseases R01AR044345 H.B), Muscular Dystrophy <br />                                                                     URLs data presented follows: <br /> Association M.C.M. H.B., William Randolph Hearst <br /> Fund M.C.M. V G., Manton Center Orphan         ANNOVAR, http://www.openbioinformatics.org/annovar/ <br /> Disease Research M.C.M., H.B., C W. Sequencing           <span id='am-7' about='obo:IMR_0001657' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-8' property="oboInOwl:id" content="IMR:0001657" datatype="xsd:string"></span><span id='am-9' property="obo:IAO_0000115" content="The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n." datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="CHEBI:23008" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="carbohydrate" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasDbXref" content="MeSH:D002241" datatype="xsd:string"></span>Carbohydrate</span>-Active Enzymes Database, www.cazy.org Sequenom genotyping Boston Children&#226;&#8364;&#8482;s Hospital          dCHIP Software, http://biosun1.harvard.edu/complab/dchip/ <br />  <br />  <br />  <br /> 546 American Journal Human Genetics 91, 541&#226;&#8364;&#8220;547, September 7, 2012 <br />  NHLBI Exome Variant Server, http://evs.gs.washington.edu/EVS/                   (2010). method server predicting damaging <br /> Online Mendelian Inheritance Man (OMIM), http://www.                         missense mutations. Nat. Methods 7, 248&#226;&#8364;&#8220;249. <br />   omim.org                                                                15.   Kumar, P., Henikoff, S., Ng, P.C. (2009). Predicting PolyPhen-2, http://genetics.bwh.harvard.edu/pph2/                               effects coding non-synonymous variants protein func- <br /> SIFT, http://sift.jcvi.org/                                                     tion using SIFT algorithm. Nat. Protoc. 4, 1073&#226;&#8364;&#8220;1081. <br />                                                                           16.   Clement, E., Mercuri, E., Godfrey, C., Smith, J., Robb, S., Kinali, <br />                                                                                 M., Straub, V., Bushby, K., Manzur, , Talim, B., et al. (2008). <br /> References <br />                                                                                 Brain involvement muscular dystrophies defective <br />  1. Dobyns, W.B., Pagon, R , Armstrong, D., Curry, C.J.,                      dystroglycan glycosylation. Ann. Neurol. 64, 573&#226;&#8364;&#8220;582. <br />     Greenberg, F., Grix, , Holmes, L.B., Laxova, R., Michels,           17.   Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., <br />     V.V., Robinow, M., et al. (1989). Diagnostic criteria                   Satz, J.S., Dollar, J., Nishino, , Kelley, R , Somer, H., et al. <br />     Walker-Warburg syndrome.  J. Med. Genet. 32, 195&#226;&#8364;&#8220;210.                    (2002). Post-translational disruption dystroglycan-ligand <br />  2. Godfrey, C., Foley, R., Clement, E., Muntoni, F. (2011).              interactions congenital muscular dystrophies. Nature 418, <br />     Dystroglycanopathies: Coming focus. Curr. Opin. Genet.                 417&#226;&#8364;&#8220;422. <br />     Dev. 21, 278&#226;&#8364;&#8220;285.                                                     18.   Hu, H., Li, J., Gagen, C.S., Gray, N.W., Zhang, , Qi, Y.,  3. Barresi, R., Campbell, K.P. (2006). Dystroglycan:                  Zhang, P. (2011). Conditional knockout protein O-manno- <br />     biosynthesis pathogenesis human disease. J. Cell Sci.                 syltransferase 2 reveals tissue-specific roles O-mannosyl <br />     119, 199&#226;&#8364;&#8220;207.                                                               glycosylation brain development. J. Comp. Neurol. 519, <br />  4. Roscioli, T., Kamsteeg, E.J., Buysse, K., Maystadt, , van Reeu-           1320&#226;&#8364;&#8220;1337. <br />     wijk, J., van den Elzen, C., van Beusekom, E., Riemersma, M.,         19.   Manzini, M.C., Walsh, C  (2011). disorders     Pfundt, R., Vissers, L.E., et al. (2012). Mutations ISPD cause           cortical development tell cortex: plus     Walker-Warburg syndrome defective glycosylation                      does make  Curr. Opin. Genet. Dev. 21, 333&#226;&#8364;&#8220;339. <br />     dystroglycan. Nat. Genet. 44, 581&#226;&#8364;&#8220;585.                              20.   Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M.E., <br />  5. Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T.,                     Yu, L., Campbell, K.P. (2012). Dystroglycan function <br />     Bernabe, D.B., Venzke, D., Cirak, S., Schachter, H., Vajsar,             requires xylosyl- glucuronyltransferase activities     J., Voit, T., et al. (2012). ISPD loss function mutations                LARGE. Science 335, 93&#226;&#8364;&#8220;96. <br />     disrupt dystroglycan O-mannosylation cause Walker-                21.   Maynard, T.M., Meechan, D.W., Dudevoir, M.L., Gopalak- <br />     Warburg syndrome. Nat. Genet. 44, 575&#226;&#8364;&#8220;580.                                  rishna, D., Peters, , Heindel, C.C., Sugimoto, T.J., Wu, Y., <br />  6. Manzini, M.C., Gleason, D., Chang, B.S., Hill, R.S., Barry, B.J.,           Lieberman, J , Lamantia, S. (2008). Mitochondrial <br />     Partlow, J.N., Poduri, , Currier, S., Galvin-Parton, P., Shapiro,         localization function subset 22q11 deletion <br />     L.R., et al. (2008). Ethnically diverse causes Walker-Warburg            syndrome candidate genes. Mol. Cell. Neurosci. 39, 439&#226;&#8364;&#8220;451. <br />     syndrome (WWS): FCMD mutations common cause                22.   Bello, L., Melacini, P., Pezzani, R., D&#226;&#8364;&#8482;Amico, , Piva, L., <br />     WWS outside Middle East. Hum. Mutat. 29, E231&#226;&#8364;&#8220;E241.               Leonardi, E., Torella, , Soraru, G., Palmieri, , Smaniotto, <br />  7. Mercuri, E., Messina, S., Bruno, C., Mora, M., Pegoraro, E.,                G., et al. (2012). Cardiomyopathy patients POMT1- <br />     Comi, G.P., D&#226;&#8364;&#8482;Amico, , Aiello, C., Biancheri, R., Berardinelli,           related congenital limb-girdle muscular dystrophy. Eur. <br />     , et al. (2009). Congenital muscular dystrophies                     J. Hum. Genet. Published online 2, 2012. http://dx.doi. <br />     defective glycosylation dystroglycan: population study.                org/10.1038/ejhg.2012.71. <br />     Neurology 72, 1802&#226;&#8364;&#8220;1809.                                              23.   Gupta, V., Kawahara, G., Gundry, S.R., Chen, T., Lencer, <br />  8. Bouchet, C., Gonzales, M., Vuillaumier-Barrot, S., Devisme, L.,             W , Zhou, Y., Zon, L , Kunkel, L.M., Beggs, H. <br />     Lebizec, C., Alanio, E., Bazin, , Bessie`res-Grattagliano, B.,            (2011). zebrafish dag1 mutant: novel genetic model <br />     Bigi, N., Blanchet, P., et al. (2007). Molecular heterogeneity           dystroglycanopathies. Hum. Mol. Genet. 20, 1712&#226;&#8364;&#8220;1725. <br />     fetal forms type II lissencephaly. Hum. Mutat. 28, 1020&#226;&#8364;&#8220;1027.      24.   Lin, Y.Y., White, R.J., Torelli, S., Cirak, S., Muntoni, F.,  9. Cormand, B., Pihko, H., Baye&#194;&#180;s, M., Valanne, L., Santavuori, P.,            Stemple, D.L. (2011). Zebrafish Fukutin family proteins link <br />     Talim, B., Gershoni-Baruch, R., Ahmad, , van Bokhoven, H.,                unfolded protein response dystroglycanopathies. <br />     Brunner, H.G., et al. (2001). Clinical genetic distinction              Hum. Mol. Genet. 20, 1763&#226;&#8364;&#8220;1775. <br />     Walker-Warburg syndrome muscle-eye-brain                  25.   Kawahara, G., Guyon, J.R., Nakamura, Y., Kunkel, L.M. <br />     disease. Neurology 56, 1059&#226;&#8364;&#8220;1069.                                           (2010). Zebrafish models human FKRP muscular dystro- <br /> 10. Lander, E.S., Botstein, D. (1987). Homozygosity mapping:                phies. Hum. Mol. Genet. 19, 623&#226;&#8364;&#8220;633. <br />     way map human recessive traits DNA inbred            26.   Thornhill, P., Bassett, D., Lochmu     &#194;&#168; ller, H., Bushby, K.,     children. Science 236, 1567&#226;&#8364;&#8220;1570.                                           Straub, V. (2008). Developmental defects zebrafish model <br /> 11. Ng, S.B., Buckingham, K.J., Lee, C., Bigham, W., Tabor, H.K.,             muscular dystrophies associated loss fukutin- <br />     Dent, K.M., Huff, C.D., Shannon, P.T., Jabs, E.W., Nickerson,               related protein (FKRP). Brain 131, 1551&#226;&#8364;&#8220;1561. <br />     D , et al. (2010). Exome sequencing identifies cause         27.   Moore, C.J., Goh, H.T., Hewitt, J.E. (2008). Genes required <br />     mendelian disorder. Nat. Genet. 42, 30&#226;&#8364;&#8220;35.                                functional glycosylation dystroglycan conserved <br /> 12. Li, H., Durbin, R. (2009). Fast accurate sho <br /> </body></html>